This week, he gives a quickie interview to Fortune magazine (to view the clip, please click here). At stake, of course, is the value of some of the biggest brand-name products - Tylenol, for instance - as well as the bragging rights of a company that has been seen as the standard by which others are judged when a corporate crisis occurs. "There are definitely who have changed and people who will be changed....We are severely disappointed in ourselves. We owe (patients) a huge apology," he says. "...We have to earn (trust) back."